Psycho-Educational Cognition Intervention in Patients With Blood and Lymph Cancer



Status:Not yet recruiting
Healthy:No
Age Range:18 - 39
Updated:1/17/2019
Start Date:June 24, 2019
End Date:June 24, 2020

Use our guide to learn which trials are right for you!

A Study of the Feasibility and Acceptability of a Psycho-Educational Cognition Intervention in Adolescents and Young Adults (AYAs) With Cancer

This pilot trial studies how well a psycho-educational program called Emerging from the Haze
works in helping patients with blood and lymph cancer. Sometimes, patients who have undergone
treatment for cancer experience thinking or memory problems that make work, school, or
everyday life activities, such as grocery shopping, difficult. The Emerging from the Haze
program may provide resources to help deal with these types of challenges in patients with
blood and lymph cancer.

PRIMARY OBJECTIVES:

I. Demonstrate feasibility and acceptability for young adult survivors of various cancers
utilizing Emerging from the Haze program.

SECONDARY OBJECTIVES:

I. Describe, summarize study population. II. Characterize, compare the measure scores at
pre-intervention assessment to the measure scores at post-intervention assessment.

OUTLINE:

Patients participate in the Emerging from the Haze psycho-educational program weekly over 2
hours for 6 weeks.

Inclusion Criteria:

- A diagnosis of a hematological malignancy.

- Having received chemotherapy with or without radiation therapy.

- Physician approval.

- Functional Assessment of Cancer Therapy-Cognition (FACT-COG) score < 59 on the
perceived cognitive impairments (PCI) subscale.

- Eligible after 2 months (60 +/- 5 days) of completing all their active cancer
treatment with the exception of patients that are post-transplant.

- Subjective complaint of cognitive concerns at time of enrollment.

- Must be able to understand and communicate proficiently in English.

- Ability to understand and the willingness to sign a written informed consent.

- Agree to complete study surveys.

Exclusion Criteria:

- Patients who have significant personality disorders or unstable psychiatric disorders
as assessed by the interviewing clinician.

- Patients with known brain metastases, history of brain metastases or radiation to the
brain.

- Patients with a history of stroke or other pre-existing neurological condition that
may contribute to cognitive dysfunction.

- Non-English speaking patients.
We found this trial at
1
site
Duarte, California 91010
Principal Investigator: Natalie Kelly, PhD
Phone: 626-256-4673
?
mi
from
Duarte, CA
Click here to add this to my saved trials